Are you meaning to say "stage 1 cancer"? If so, I doubt anyone here can give an answer. When Leo was asked in San Francisco at the Q&A for the Biotech Showcase he said they had no idea how the next trial would be designed until the full results of the current phase I kevetrin trial are in. (current trial treats stage 4 cancer patients)
I've always found the idea of using kevetrin as a preventative fascinating.
In Reply to 'DaubersUP' When does Kevetrin get to go against phase 1 cancer or even cancer prevention? Sorry for the fully loaded question guys. For all you board doctor experts that I miss so much! Would the moa of K work at an earlier/prevention stage?